🧴🎁 Free 10ML BAC Water on Every Order
📦✅ Free Express Home Delivery Worldwide
🧴🎁 Free 10ML BAC Water on Every Order
📦✅ Free Express Home Delivery Worldwide

CJC-1295-5MG

Categories:

CJC-1295 5MG is a synthetic growth hormone–releasing hormone (GHRH) analog investigated in endocrine, metabolic, and laboratory research. CJC-1295 formulations may differ depending on whether a drug-affinity complex (DAC) modification is present, so the exact product identity should be confirmed using the product label and batch-specific documentation.

$90.00

Satisfaction Guaranteed

Secure
Payment

Third-party
Tested

CJC-1295 5MG

CJC-1295 5MG is a synthetic growth hormone–releasing hormone (GHRH) analog investigated in endocrine, metabolic, and laboratory research. CJC-1295 formulations may differ depending on whether a drug-affinity complex (DAC) modification is present, so the exact product identity should be confirmed using the product label and batch-specific documentation.

Research Context

Research involving CJC-1295 examines GHRH receptor signaling, endogenous growth hormone secretion, insulin-like growth factor 1 (IGF-1) regulation, and downstream endocrine pathways. Experimental and clinical studies have investigated modified GHRH analogs for their pharmacokinetic properties and prolonged stimulation of growth hormone–related signaling.

Research Overview

Laboratory research involving CJC-1295 may evaluate receptor binding, intracellular signaling, growth hormone release, IGF-1-associated responses, and peptide stability. The presence or absence of DAC can substantially affect pharmacokinetic characteristics and experimental behavior, so findings from one formulation should not automatically be applied to another.

Key Research Focus Areas

  • GHRH Receptor Research: Investigation of GHRH receptor binding and downstream signaling pathways.
  • Growth Hormone Research: Study of endogenous growth hormone secretion and associated endocrine communication.
  • IGF-1 Signaling: Evaluation of IGF-1-associated molecular and metabolic pathways.
  • Endocrine Research: Investigation of feedback mechanisms and interactions within the growth hormone axis.
  • Peptide Characterization: Evaluation of identity, purity, stability, compatibility, and analytical properties under standardized research protocols.

Important Compliance and Safety Information

CJC-1295 is an investigational research compound and should not be represented as an approved human or veterinary therapeutic. The 5MG designation indicates the quantity supplied and does not by itself establish concentration, formulation, route of administration, or intended use.

For research use only. Not for human or animal consumption.

CJC-1295 5MG is a synthetic growth hormone–releasing hormone (GHRH) analog investigated in endocrine, metabolic, and laboratory research. CJC-1295 formulations may differ depending on whether a drug-affinity complex (DAC) modification is present, so the exact product identity should be confirmed using the product label and batch-specific documentation.
Lab Report

Research Use Disclaimer

Research Use Only: All products offered are intended strictly for laboratory research purposes. Products are not for human consumption and are not intended for diagnostic, therapeutic, or medical use. By purchasing from our website, customers confirm they are qualified researchers or laboratories and understand the intended research-use designation.

Related Compounds

Access Agreement Required

This site is restricted to 21+ users; all products are for laboratory research use only, are not FDA-approved, and are not intended for human/animal use or to diagnose, treat, cure, or prevent disease.

*By continuing, you confirm eligibility and legal compliance.